# US 2021/0239676 A1 · Method and system for evaluation of drug concentration in blood, plasma or serum

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2021/0239676 A1
- Document ID: US20210239676A1
- Status: Published application
- Kind: A1
- Application number: 15/734,743
- Filed: 2019-06-03
- Published: 2021-08-05
- Earliest claimed: 2018-06-07
- Assignees: Pharmacolog I Uppsala AB
- Applicants: Pharmacolog I Uppsala AB
- Inventors: Hans DAHLIN; Jörgen HÖJDMO
- Web page: https://patentgrep.com/patent/US20210239676A1

## CPC

- G01N 33/48714: {for determining substances foreign to the organism, e.g. drugs or heavy metals (drugs by chemical analysis G01N33/94)}
- A61M 5/14: Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61M 5/1723: {using feedback of body parameters, e.g. blood sugar or pressure}
- G01N 21/31: Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry {(G01N21/72 takes precedence)}
- A61M 2205/3306: Optical measuring means
- A61M 2205/50: with microprocessors or computers
- G01N 2800/52: Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)
- A61M: DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY (introducing media into or onto the bodies of animals A61D7/00; means for inserting tampons A61F13/26; devices for administering food or medicines orally A61J; containers for collecting, storing or administering blood or medical fluids A61J1/05); DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY (surgery A61B; chemical aspects of surgical articles A61L); DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR {(Electrotherapy, e.g. producing anaesthesia by the use of alternating or intermittent currents A61N1/36021)}

## Abstract

A method and a system for evaluating a drug concentration in body fluid samples, wherein the body fluid samples are blood, plasma or serum, the method including the steps of: preparing at least one body fluid sample including a solved target drug by removing unsolved components from the body fluid sample; performing absorption spectrophotometric analyzes on the at least one body fluid sample; and evaluating a drug concentration in the at least one body fluid sample based on the spectrophotometric analyzes.

## Claims

### Claim 1

A method for evaluating a drug concentration in body fluid samples, wherein said body fluid samples are blood, plasma or serum, said method comprising the steps of:
preparing (S1) at least one body fluid sample comprising a solved target drug by removing unsolved components from the body fluid sample;
performing (S3) absorption spectrophotometric analyzes on the at least one body fluid sample;
evaluating (S5) a drug concentration in the at least one body fluid sample based on the spectrophotometric analyzes.

### Claim 2 (depends on 1)

The method according to claim 1, wherein a drug concentration is evaluated in at least two body fluid samples taken at different times during treatment of a patient with said drug and wherein the method further comprises the step of:
determining (S7) a change in drug concentration between the at least two body fluid samples by comparing the spectrophotometric analyzes for the different body fluid samples.

### Claim 3 (depends on 1)

The method according to claim 1, further comprising the step of:
monitoring (S9) drug concentration changes over time in a body fluid from a patient during treatment of said patient with said drug by evaluating a drug concentration in a number of body fluid samples taken at different times during treatment of a patient with said drug.

### Claim 4 (depends on 1)

The method according to claim 1, wherein the step of preparing (S1) the at least one body fluid sample comprises removing lipids, blood cells and other unsolved components.

### Claim 5 (depends on 1)

The method according to claim 1, wherein the step of preparing (S1) the at least one body fluid sample comprises diluting (S1a) the body fluid sample.

### Claim 6 (depends on 1)

The method according to claim 1, wherein the step of preparing (S1) at least one body fluid sample comprises:
centrifuging (S1b) the body fluid sample; and
collecting (S1c) a fraction from the centrifuged body fluid sample for further use in the spectrophotometric analyzes.

### Claim 7 (depends on 1)

The method according to claim 1, wherein the step of preparing (S1) the at least one body fluid sample comprises filtering (S1d) the body fluid sample before performing the spectrophotometric analyzes.

### Claim 8 (depends on 1)

The method according to claim 1, wherein the step of preparing (S1) at least one body fluid sample comprises:
diluting (S1a) the at least one body fluid sample;
centrifuging (S1b) the body fluid sample;
collecting (S1c) a middle fraction from the centrifuged body fluid sample;
filtering (S1d) said middle fraction through a bacteria filter (5) for further use in the spectrophotometric analyzes.

### Claim 9 (depends on 1)

The method according to claim 1, wherein said method is performed bed side, during treatment of a patient with the drug.

### Claim 10 (depends on 1)

The method according to claim 1, wherein said drug is antibiotics or cytostatics.

### Claim 11 (depends on 1)

The method according to claim 1, wherein the step of evaluating (S5) the drug concentration in the body fluid sample comprises comparing the spectrophotometric analyzes with pre-stored spectrophotometric spectra for this specific drug at different concentrations and with a patient reference spectra which is a spectrophotometric spectra for at least one body fluid sample from this specific patient taken before a start of a treatment or in the beginning of a treatment of the patient.

### Claim 12 (depends on 1)

A method for administering of a drug to a patient comprising:
adapting a drug dose to be administered to the patient in accordance with an evaluation of a drug concentration in body fluid samples taken from the patient during the administration of the drug according to claim 1.

### Claim 13 (depends on 12)

The method according to claim 12, wherein said adaptation of the drug dose and said evaluation of a drug concentration in a body fluid sample are done repeatedly during treatment of the patient with the drug.

### Claim 14

A system (1) for evaluating a drug concentration in body fluid samples, wherein said body fluid samples are blood, plasma or serum, said system comprising:
a preparation unit (3), in which at least one body fluid sample comprising a solved target drug is prepared by removing unsolved components from the body fluid sample;
an absorption spectrophotometer (11) provided for receiving prepared body fluid samples from the preparation unit (3) for performing absorption spectrophotometric analyzes on the at least one body fluid sample;
an evaluation module (17) connected to the spectrophotometer (11) for receiving analyzes results therefrom and configured for evaluating a drug concentration in the at least one body fluid sample based on the spectrophotometric analyzes.

### Claim 15 (depends on 14)

The system according to claim 14, wherein the preparation unit (3) is configured for removing lipids, blood cells and other unsolved components.

### Claim 16 (depends on 14)

The system according to claim 14, wherein said preparation unit (3) comprises a dilution station (7) for diluting said at least one body fluid sample.

### Claim 17 (depends on 15)

The system according to claim 15, wherein said preparation unit (3) further comprises:
a centrifuging device (9) arranged for centrifuging said at least one body fluid sample; and
a fraction collection station (10) arranged for allowing collection of a fraction of the centrifuged body fluid sample.

### Claim 18 (depends on 14)

The system according to claim 14, wherein said preparation unit (3) comprises a filter (5) for filtering said at least one body fluid sample.

### Claim 19 (depends on 14)

The system according to claim 14, wherein said preparation unit (3) comprises:
a dilution station (7) for diluting said at least one body fluid sample;
a centrifuging device (9) connected to the dilution station and arranged for centrifuging said at least one diluted body fluid sample;
a fraction collection station (10) arranged for allowing collection of a middle fraction of the at least one centrifuged body fluid sample;
a filter (5), which is a bacteria filter, connected to the fraction collection station (10) and arranged for filtering said collected fraction of the at least one body fluid sample before transferring it to the spectrophotometer (11).

### Claim 20 (depends on 14)

The system according to claim 14, wherein the evaluation module (17) is arranged to compare the spectrophotometric analyzes with pre-stored spectrophotometric spectra for this specific drug at different concentrations and with a patient reference spectra which is a spectrophotometric spectra for at least one body fluid sample from this specific patient taken before a start of a treatment or in the beginning of a treatment of the patient.

### Claim 21 (depends on 14)

A drug administering system (31) comprising:
a drug administering device (33) for administering a drug to a patient;
a control unit (21) connected to said drug administering device (33) for controlling a dose of said drug being administered to the patient;
a system (1) for evaluating a drug concentration in body fluid samples according to claim 14,
wherein said control unit (21) is connected to said system (1) for evaluating a drug concentration and is arranged to control a dose of said drug being administered to the patient from said drug administering device (33) in accordance with said evaluated drug concentration.
